ACHC

equitynet selling

Acadia Healthcare Company Inc · NASDAQ NMS - GLOBAL MARKET

View price on Yahoo Finance ↗
Disclosed trades
1
0 buys · 1 sells
Members involved
1
Estimated volume
$8K
sum of ranges
Most recent
Nov 30, 2022
since Nov 30, 2022

Buy it with play money

Fills at the latest stored close and lands in your paper portfolio

Sign in to buy ACHC with $10,000 of play money and watch it from here.

Sign in to trade

Price, and when Congress traded it

Hollow marks where they traded, filled where the filing went public

ACHC closing price, with each disclosed trade marked at the date it happened and the date it was filed$8$36$63Oct 24Oct 25Oct 26
they tradedyou found outthe delaygreen buys · red sells

Hover a marker to see who traded and what it was worth.

If you had bought it yourself

Paid at that day's close, held ever since. No member involved.

Amount
Latest stored close.

Working it out…

Financials

As each period's own 10-K or 10-Q reported it

Market value
$2.7B
P/E
—
P/S
0.8×
P/B
1.4×
FCF yield
-11.0%
EV/EBITDA
—
Fair value
—
Dividend yield
—

At the $29.25 close on Oct 9, 2026, against 90.76M shares and the balance sheet at Mar 31, 2026; earnings, sales and cash flow over the four quarters to Mar 31, 2026. A ratio is left out where its denominator is not positive. Fair value is the company's own median P/E, price to sales and price to free cash flow at its last ten fiscal year ends, applied to its trailing figures, the middle of the three: its valuation against its own past, not against its growth or its rivals.

Line itemFY 2016
Dec 31, 2016
FY 2017
Dec 31, 2017
FY 2018
Dec 31, 2018
FY 2019
Dec 31, 2019
FY 2020
Dec 31, 2020
FY 2021
Dec 31, 2021
FY 2022
Dec 31, 2022
FY 2023
Dec 31, 2023
FY 2024
Dec 31, 2024
FY 2025
Dec 31, 2025
Revenue$2.8B$2.8B$3B$3.1B$2.1B$2.3B$2.6B$2.9B$3.2B$3.3B
Gross margin——————————
Operating income$608.6M$604.4M$593.6M$585.9M——————
Operating margin21.6%21.3%19.7%18.9%——————
Net income$6.1M$199.8M-$175.8M$108.9M-$672.1M$190.6M$273.1M-$21.7M$255.6M-$1.1B
Net margin0.2%7.0%-5.8%3.5%-32.2%8.2%10.5%-0.7%8.1%-33.3%
EPS (diluted)$0.07$2.30-$2.01$1.24-$7.59$2.10$2.98-$0.24$2.78-$12.16
Operating cash flow$361.5M$399.6M$414.1M$332.9M$658.8M$374.5M$380.6M$462.3M$129.7M$131.9M
Capital spending$307.5M$274.2M$341.5M$284.7M$216.6M$244.8M$296.1M$424.1M$690.4M$571.8M
Free cash flow$54M$125.4M$72.6M$48.2M$442.2M$129.7M$84.4M$38.2M-$560.7M-$439.9M
Buybacks—————————$50M
Dividends paid——————————
Cash$57.1M$67.3M$50.5M$124.2M$378.7M$133.8M$97.6M$100.1M$76.3M$133.2M
Debt$3.3B$3.2B$3.2B$3.1B$3.1B$1.5B$1.4B$1.4B$2B$2.5B
Shareholders' equity$2.2B$2.6B$2.3B$2.5B$1.9B$2.5B$2.8B$2.8B$3.1B$1.9B
Shares outstanding86.69M87.06M87.44M87.72M88.02M89.03M89.91M91.26M91.78M90.45M

Figures come from the company's XBRL filings as the SEC publishes them. Quarters are worked out from year-to-date figures, and a fourth quarter is the year less its first nine months, which is why it has no EPS: per-share figures do not subtract. Earlier years are on today's share basis where a split has happened since. A later restatement is not mixed into a year it was never applied to, so where a 10-K restated the year before — a business sold, say — that year's fourth quarter is left blank rather than worked out across two bases. A dash means the company did not report that line under a standard tag for that period. Every filing on EDGAR.

Short interest

Shares sold short, as brokers report them to FINRA twice a month

Shares short
22.77M
at Sep 30, 2026
Of shares outstanding
25.1%
Days to cover
13.9
Since the last report
+5.9%
from 21.51M at Sep 15, 2026
Oct 15, 2024: 5.57M shares shortOct 31, 2024: 5.99M shares shortNov 15, 2024: 6.55M shares shortNov 29, 2024: 6.81M shares shortDec 13, 2024: 6.85M shares shortDec 31, 2024: 6.67M shares shortJan 15, 2025: 5.92M shares shortJan 31, 2025: 5.51M shares shortFeb 14, 2025: 5.76M shares shortFeb 28, 2025: 5.12M shares shortMar 14, 2025: 6.52M shares shortMar 31, 2025: 7.09M shares shortApr 15, 2025: 7.54M shares shortApr 30, 2025: 8.4M shares shortMay 15, 2025: 9.59M shares shortMay 30, 2025: 9.61M shares shortJun 13, 2025: 9.3M shares shortJun 30, 2025: 11.05M shares shortJul 15, 2025: 10.6M shares shortJul 31, 2025: 10.54M shares shortAug 15, 2025: 10.78M shares shortAug 29, 2025: 11.84M shares shortSep 15, 2025: 11.91M shares shortSep 30, 2025: 14.16M shares shortOct 15, 2025: 12.1M shares shortOct 31, 2025: 11.3M shares shortNov 14, 2025: 11.65M shares shortNov 28, 2025: 14.47M shares shortDec 15, 2025: 16.65M shares shortDec 31, 2025: 19.41M shares shortJan 15, 2026: 21.97M shares shortJan 30, 2026: 26.36M shares shortFeb 13, 2026: 32.45M shares shortFeb 27, 2026: 27.53M shares shortMar 13, 2026: 25.06M shares shortMar 31, 2026: 22.08M shares shortApr 15, 2026: 22.14M shares shortApr 30, 2026: 23.84M shares shortMay 15, 2026: 22.64M shares shortMay 29, 2026: 22.96M shares shortJun 15, 2026: 20.28M shares shortJun 30, 2026: 22.54M shares shortJul 15, 2026: 21.8M shares shortJul 31, 2026: 21.8M shares shortAug 14, 2026: 20.95M shares shortAug 31, 2026: 22.58M shares shortSep 15, 2026: 21.51M shares shortSep 30, 2026: 22.77M shares short
Oct 15, 2024Sep 30, 2026
Settlement dateShares shortChangeDays to cover
Sep 30, 202622.77M+5.9%13.9
Sep 15, 202621.51M-4.8%18.8
Aug 31, 202622.58M+7.8%12.7
Aug 14, 202620.95M-3.9%12.5
Jul 31, 202621.8M+0.0%6.7
Jul 15, 202621.8M-3.3%7.2
Jun 30, 202622.54M+11.1%5.4
Jun 15, 202620.28M-11.7%8.4

Largest fails to deliver, the last year

59 settlement days with at least $10,000 of shares sold and not delivered

Settlement dateSharesValue
Jun 22, 2026261.2K$6.5M
Jul 10, 2026180.76K$5.7M
Jun 18, 2026218.41K$5.1M
Jun 10, 2026171.77K$4.4M
Mar 17, 2026167.16K$3.8M

Short interest is every broker's short position at the settlement date, reported to FINRA and published about a week and a half later; it does not say who is short. Days to cover is the short position over the average day's trading, and the share of the company is against the shares outstanding on its latest filing. A fail to deliver is the balance of shares sold and not delivered by settlement, from the SEC: it can be a short seller who never borrowed the stock, but is as often a late delivery that clears within days.

What they lobby on

Disclosed to the Senate, largest spend first

  • KING & SPALDING LLP$60K

    Health Issues

    2nd Quarter (Apr 1 - June 30) 2026

  • KING & SPALDING LLP$60K

    Health Issues

    1st Quarter (Jan 1 - Mar 31) 2026

  • RUBIN, TURNBULL & ASSOCIATES$30K

    Health Issues

    2nd Quarter (Apr 1 - June 30) 2026

  • RUBIN, TURNBULL & ASSOCIATES$30K

    Health Issues

    1st Quarter (Jan 1 - Mar 31) 2026

  • ARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP)—

    2nd Quarter (Apr 1 - June 30) 2026

  • ARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP)—

    1st Quarter (Jan 1 - Mar 31) 2026

Federal contracts

Largest awards of the last two years

  • Department of Health and Human Services$622.3K

    ACADIA HEALTHCARE, INC · from Sep 30, 2021

  • Department of Justice$17.8K

    ACADIA HEALTHCARE COMPANY, INC. · from Mar 13, 2025

  • Department of Justice$0

    ACADIA HEALTHCARE COMPANY, INC. · from Apr 24, 2024

  • Department of Justice$0

    ACADIA HEALTHCARE COMPANY, INC. · from Apr 17, 2024

More on ACHC

Who traded it

Most active first

MemberBuysSells
Susie LeeNV-03 · house—1

Every disclosure

1 in total, newest first

MemberAmount
Susie LeeNV · houseselljoint$1K – $15K

Follow Acadia Healthcare Company Inc (ACHC) by email

New trades in Acadia Healthcare Company Inc (ACHC) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.